Richard N Re,Julia L Cook
Richard N Re
Over the past 3 decades it has become clear that a large number of extracellular signaling proteins/peptides also act in the intracellular space. These factors are termed intracrines and, although diverse in structure, they share a variety ...
Association of self-reported race/ethnicity and genetic ancestry with arterial elasticity: the Multi-Ethnic Study of Atherosclerosis (MESA) [0.03%]
种族/族裔自我认同和遗传祖先与动脉弹性之间的关系：动脉粥样硬化多种族研究(MESA)的一项研究
Christina L Wassel,David R Jacobs Jr,Daniel A Duprez et al.
Christina L Wassel et al.
African Americans have a disproportionate burden of hypertension compared with white, whereas data on Hispanics is less well-defined. Mechanisms underlying these differences are unclear, but could be in part because of ancestral background ...
Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified [0.03%]
住院患者的血压管理中使用静脉注射长效盐酸肼普拉往往缺乏依据
Patrick Campbell,William L Baker,Stephen D Bendel et al.
Patrick Campbell et al.
Due to observations of increased off-label use of intravenous hydralazine in area hospitals, we studied its use in a university teaching hospital. Patients were prospectively identified between April and October 2010 with a pharmacy order f...
Is salt intake an independent risk factor of stroke mortality? Demographic analysis by regions in Japan [0.03%]
食盐摄入是脑卒中的独立危险因素吗？日本地区差异的流行病学分析
Tatsuya Tomonari,Michio Fukuda,Toshiyuki Miura et al.
Tatsuya Tomonari et al.
We reported a remarkable regional difference within Japan in the incidence of end-stage renal disease. Regional differences were also well-known for salt intake, blood pressure (BP), and mortality from stroke, which remains one of the leadi...
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, A [0.03%]
2011年美国心脏病学会/美国心脏协会高血压老年患者专家共识文件：美国心脏病学院临床专家共识文件工作组与美国神经病学学会、美国老年医学会、美国预防心血管疾病学会、美国高血压学会等合作制定的报告
Wilbert S Aronow,Jerome L Fleg,Carl J Pepine et al.
Wilbert S Aronow et al.
Hypertension in diverse populations: a New York State Medicaid clinical guidance document [0.03%]
高血压的多元化人群管理：纽约州医疗补助临床指南文档
Mark J Wrobel,James J Figge,Joseph L Izzo Jr
Mark J Wrobel
The New York State Medicaid Prescriber Education Program (PEP) is a partnership between the Department of Health and state academic institutions that provides prescribers with an evidence-based, noncommercial source of the latest objective ...
From the editor [0.03%]
编者来信
Myron H Weinberger
Myron H Weinberger
Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations [0.03%]
用于识别未来发病风险的血管和心脏功能及结构筛查：初步观察结果
Daniel A Duprez,Natalia Florea,Wei Zhong et al.
Daniel A Duprez et al.
Risk factors have served to identify patients in need of antihypertensive and lipid-lowering therapy. Because of their limited sensitivity and specificity, we developed a screening program using noninvasive testing and a scoring system aime...
Brigitte M Baumann,David M Cline,Eduardo Pimenta
Brigitte M Baumann
This review updates concepts of hypertension evaluation and management in patients presenting to the emergency department. It outlines the current challenges faced by emergency physicians in the identification and management of hypertensive...
The effect of eprosartan on reflex sympathetic activation in sodium restricted patients with essential hypertension [0.03%]
限制钠摄入的原发性高血压患者中厄沙坦对反射性交感神经激活的影响
Henrik Vase,Thomas G Lauridsen,Carolina C Graffe et al.
Henrik Vase et al.
AT(1) receptor antagonists possess sympathoinhibitory effects in animal experiments, but in human studies the results are conflicting. We tested the hypothesis that very short-term treatment with the AT(1) receptor antagonist eprosartan inh...
Randomized Controlled Trial
Journal of the American Society of Hypertension : JASH. 2011 Sep-Oct;5(5):385-94. DOI:10.1016/j.jash.2011.03.007 2011